25
Translating Emerging HIV Data Into Clinical Practice

Translating Emerging HIV Data Into Clinical Practice

Embed Size (px)

DESCRIPTION

Translating Emerging HIV Data Into Clinical Practice. ART and the Search for an HIV Cure. The Mississippi Child : An Update on A Presumptive Cure With Early ART. “Kick and Kill”: Reducing the Latent HIV Reservoir. - PowerPoint PPT Presentation

Citation preview

Page 1: Translating Emerging HIV Data Into Clinical Practice

Translating Emerging HIV Data Into Clinical Practice

Page 2: Translating Emerging HIV Data Into Clinical Practice
Page 3: Translating Emerging HIV Data Into Clinical Practice
Page 4: Translating Emerging HIV Data Into Clinical Practice

ART and the Search for an HIV Cure

Page 5: Translating Emerging HIV Data Into Clinical Practice

The Mississippi Child: An Update on A Presumptive Cure

With Early ART

Page 6: Translating Emerging HIV Data Into Clinical Practice

“Kick and Kill”: Reducing the Latent HIV

Reservoir

Page 7: Translating Emerging HIV Data Into Clinical Practice

PrEP: Implementation, Management Considerations, and

Identifying At-Risk Populations

Page 8: Translating Emerging HIV Data Into Clinical Practice

PrEP US Demo Project: Baseline Risk Behaviors and

PrEP Acceptance

Page 9: Translating Emerging HIV Data Into Clinical Practice

iPrEx OLE Study: Perfect Adherence Not Necessary for

Effective PrEP

Page 10: Translating Emerging HIV Data Into Clinical Practice

ANRS Ipergay Study: High Rate of Adherence to Intermittent

Oral PrEP

Page 11: Translating Emerging HIV Data Into Clinical Practice

HIV Management: Regimen Simplification and Options for

Resistant Variants

Page 12: Translating Emerging HIV Data Into Clinical Practice

OLE Study: Dual Therapy With LPV/r + 3TC Noninferior to

LPV/r + 2 NRTIs

Page 13: Translating Emerging HIV Data Into Clinical Practice

SALT Study: Switch to ATV/r + 3TC Noninferior to ATV/r + 2

NRTIs

Page 14: Translating Emerging HIV Data Into Clinical Practice

HARNESS Study: Increased Virologic Rebound ATV/r + RAL vs ATV/r + TDF/FTC

Page 15: Translating Emerging HIV Data Into Clinical Practice

DTG-based Regimens Active in Patients INSTI-Naïve, NRTI-

Resistant

Page 16: Translating Emerging HIV Data Into Clinical Practice

Treating the Patient With HIV/HCV Coinfection

Page 17: Translating Emerging HIV Data Into Clinical Practice

PHOTON-2: SOF + RBV Yields High SVR12 in HIV/HCV

Coinfection

Page 18: Translating Emerging HIV Data Into Clinical Practice

TURQUOISE-I: Novel 3 Drug Regimen + RBV Safe and Efficacious for HIV/HCV

Coinfection

Page 19: Translating Emerging HIV Data Into Clinical Practice

DTG-Based Regimens’ Comparable Results in HIV/HCV Coinfected vs HIV Monoinfected

Page 20: Translating Emerging HIV Data Into Clinical Practice

Abbreviations

Page 21: Translating Emerging HIV Data Into Clinical Practice

Abbreviations (cont)

Page 22: Translating Emerging HIV Data Into Clinical Practice

Abbreviations (cont)

Page 23: Translating Emerging HIV Data Into Clinical Practice

References

Page 24: Translating Emerging HIV Data Into Clinical Practice

References (cont)

Page 25: Translating Emerging HIV Data Into Clinical Practice

References (cont)